Related references
Note: Only part of the references are listed.Germline variants drive myelodysplastic syndrome in young adults
Simone Feurstein et al.
LEUKEMIA (2021)
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
Anna L. Brown et al.
BLOOD (2020)
NCCN: Continuing Education
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
Deepak Singhal et al.
LEUKEMIA (2019)
Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Featured Updates to the NCCN Guidelines
Samir Gupta et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
Marie Sebert et al.
BLOOD (2019)
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Sarah E. Brnich et al.
GENOME MEDICINE (2019)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Donor-derived MDS/AML in families with germline GATA2 mutation
Pallavi Galera et al.
BLOOD (2018)
Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion
Ahmad N. Abou Tayoun et al.
HUMAN MUTATION (2018)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation
G. Berger et al.
LEUKEMIA (2017)
Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations
Christen L. Ebens et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
L. Guidugli et al.
LEUKEMIA (2017)
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
Maya Lewinsohn et al.
BLOOD (2016)
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia
Jane E. Churpek et al.
CANCER (2016)
How I treat MDS and AML in Fanconi anemia
Regis Peffault de Latour et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Chantana Polprasert et al.
CANCER CELL (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fanconi anemia gene variants in therapy-related myeloid neoplasms
M. T. Voso et al.
BLOOD CANCER JOURNAL (2015)
Realizing the promise of cancer predisposition genes
Nazneen Rahman
NATURE (2014)
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
Eduard Schulz et al.
JOURNAL OF MEDICAL GENETICS (2012)
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation
Haowen Xiao et al.
BLOOD (2011)
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita
A. C. Dietz et al.
BONE MARROW TRANSPLANTATION (2011)
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
Marielle W. G. Ruijs et al.
JOURNAL OF MEDICAL GENETICS (2010)
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Julie Tinat et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
BRCA1 and BRCA2 Nucleotide Variants in Young Women with Therapy Related Acute Myeloid Leukemia.
Michael G. Martin et al.
BLOOD (2009)
PTPN11 mutations in Noonan syndrome:: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Sensitivity and predictive value of criteria for p53 germline mutation screening
A Chompret et al.
JOURNAL OF MEDICAL GENETICS (2001)
Share Paper
